On July 4, MEDIPOST announced that it has obtained a Japanese patent for stem cell composition that prevent hair loss.
The tile of this patent is ‘Hair growth-promoting function of small-sized stem cells and use thereof’ and the patent is about compound that prevents hair loss and promotes hair growth by using small stem cells or culture medium.
Medipost official said, “This technology that proves that a small mesenchymal stem cell or culture medium from cord blood can prevent hair loss and promote hair growth “.
Medipost has been working on the Global Advanced Bio-Medical Technology Development Project, jointly promoted by the Ministry of Science, Technology and Communication and Welfare as a government-supported organization.
Medipost plans to use the patent as the basis for research on hair loss using SMUP-Cell, a next-generation efficient stem cell treatment.
Meanwhile, Medipost will hold 76 patents in such areas as cord blood and cord blood stem cell treatment technology.